Who
In numbers
- Trades disclosed
- 93
- Buys
- 0
- Sells
- 13
- Bought
- $0
- Sold
- $7.3M
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 22 Sep 2025
- Last trade
- 29 Sep 2026
- Last filed
- 1 Oct 2026
Companies traded
Activity over time
1 Dec 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 29 Sep 2026filed 1 Oct 2026 | MAZE Maze TherapeuticsBiotechnology | SEC FORM 4 Code M | $78K7,500 at $10.42 | filing |
| 29 Sep 2026filed 1 Oct 2026 | MAZE Maze TherapeuticsBiotechnology | SEC FORM 4 Sold | $203K7,500 at $27.06 | filing |
| 29 Sep 2026filed 1 Oct 2026 | MAZE Maze Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —7,500 at $0.00 | filing |
| 3 Sep 2026filed 4 Sep 2026 | MAZE Maze TherapeuticsBiotechnology | SEC FORM 4 Sold | $83K3,207 at $26.01 | filing |
| 3 Sep 2026filed 4 Sep 2026 | MAZE Maze TherapeuticsBiotechnology | SEC FORM 4 Sold | $92936 at $25.81 | filing |
| 3 Sep 2026filed 4 Sep 2026 | MAZE Maze TherapeuticsBiotechnology | SEC FORM 4 Sold | $83K3,207 at $26.01 | filing |
| 3 Sep 2026filed 4 Sep 2026 | MAZE Maze TherapeuticsBiotechnology | SEC FORM 4 Sold | $92936 at $25.81 | filing |
| 2 Sep 2026filed 4 Sep 2026 | MAZE Maze TherapeuticsBiotechnology | SEC FORM 4 Sold | $74K2,800 at $26.38 | filing |
| 2 Sep 2026filed 4 Sep 2026 | MAZE Maze TherapeuticsBiotechnology | SEC FORM 4 Sold | $11K391 at $27.12 | filing |
| 2 Sep 2026filed 4 Sep 2026 | MAZE Maze TherapeuticsBiotechnology | SEC FORM 4 Sold | $74K2,800 at $26.38 | filing |
| 2 Sep 2026filed 4 Sep 2026 | MAZE Maze TherapeuticsBiotechnology | SEC FORM 4 Sold | $11K391 at $27.12 | filing |
| 1 Sep 2026filed 3 Sep 2026 | MAZE Maze TherapeuticsBiotechnology | SEC FORM 4 Code M | —12,500 at $0.00 | filing |
| 1 Sep 2026filed 3 Sep 2026 | MAZE Maze Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —12,500 at $0.00 | filing |
| 1 Sep 2026filed 3 Sep 2026 | MAZE Maze Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —12,500 at $0.00 | filing |
| 1 Sep 2026filed 3 Sep 2026 | MAZE Maze TherapeuticsBiotechnology | SEC FORM 4 Code M | —12,500 at $0.00 | filing |
| 28 Aug 2026filed 31 Aug 2026 | MAZE Maze TherapeuticsBiotechnology | SEC FORM 4 Code M | $78K7,500 at $10.42 | filing |
| 28 Aug 2026filed 31 Aug 2026 | MAZE Maze TherapeuticsBiotechnology | SEC FORM 4 Sold | $207K7,500 at $27.58 | filing |
| 28 Aug 2026filed 31 Aug 2026 | MAZE Maze Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —7,500 at $0.00 | filing |
| 28 Aug 2026filed 31 Aug 2026 | MAZE Maze Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code M | —7,500 at $0.00 | filing |
| 28 Aug 2026filed 31 Aug 2026 | MAZE Maze TherapeuticsBiotechnology | SEC FORM 4 Code M | $78K7,500 at $10.42 | filing |
News
Maze Therapeutics (NASDAQ:MAZE) Stock Rated "Buy" in New Coverage at Canaccord Genuity GroupMAZE · themarketsdaily.com · 20 Oct 2026Head to Head Survey: Maze Therapeutics (NASDAQ:MAZE) vs. Cytokinetics (NASDAQ:CYTK)MAZE · dailypolitical.com · 18 Oct 2026
0 headlines in the last 90 days name Atul Dandekar; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.